Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 822,231 shares of the real estate investment trust's stock, valued at approximately $14,241,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.35% of Sabra Health Care REIT at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. VSM Wealth Advisory LLC acquired a new stake in shares of Sabra Health Care REIT during the 4th quarter worth about $26,000. Assetmark Inc. boosted its holdings in Sabra Health Care REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock valued at $45,000 after acquiring an additional 656 shares during the period. GF Fund Management CO. LTD. purchased a new position in Sabra Health Care REIT during the 4th quarter valued at about $74,000. Jones Financial Companies Lllp boosted its holdings in Sabra Health Care REIT by 208.3% during the 4th quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock valued at $108,000 after acquiring an additional 4,204 shares during the period. Finally, FIL Ltd boosted its holdings in Sabra Health Care REIT by 40.4% during the 4th quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust's stock valued at $113,000 after acquiring an additional 1,873 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.
Sabra Health Care REIT Stock Up 0.4%
Shares of Sabra Health Care REIT stock traded up $0.07 on Friday, reaching $17.49. 2,221,737 shares of the company were exchanged, compared to its average volume of 2,222,123. Sabra Health Care REIT, Inc. has a 1-year low of $13.87 and a 1-year high of $20.03. The company has a market cap of $4.16 billion, a P/E ratio of 33.00, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The stock's 50 day moving average price is $17.54 and its 200-day moving average price is $17.33.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. During the same quarter in the previous year, the business earned $0.35 earnings per share. The firm's revenue was up 10.1% compared to the same quarter last year. As a group, equities analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.
Sabra Health Care REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.86%. The ex-dividend date of this dividend was Friday, May 16th. Sabra Health Care REIT's dividend payout ratio is currently 203.39%.
Analysts Set New Price Targets
SBRA has been the subject of a number of research analyst reports. Truist Financial raised their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Scotiabank boosted their price objective on Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research report on Monday, May 12th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Sabra Health Care REIT currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.50.
Check Out Our Latest Report on SBRA
Insider Buying and Selling at Sabra Health Care REIT
In related news, Director Michael J. Foster sold 11,000 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director now owns 64,725 shares of the company's stock, valued at $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.10% of the stock is owned by company insiders.
Sabra Health Care REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also

Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.